Effect of a Fasting Mimicking Diet on Patients With Multiple Sclerosis (FMDMS)
50
about 2 years
18–55
1 site in CA
About this study
Researchers are testing if a fasting mimicking diet improves the quality of life for people with relapsing multiple sclerosis who are already taking disease-modifying therapies. The trial will compare this to a Mediterranean diet control group.
Based on ClinicalTrials.gov records.
What participants do
- 1.Med Diet. Investigators would like to see what differences a Mediterranean Diet makes to the status of patients with Multiple Sclerosis
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Health-related Quality of Life (HRQOL)
Secondary: Assessing Safety and Tolerability of a FMD in MS: Compliance and Serious Adverse Events, To evaluate alterations in immune function by assessing changes in cell counts, serum cytokines and secretion patterns, with a focus on pro-inflammatory cytokines IL-2, interferon-gamma (IFNγ), and IL-17A, and the regulatory cytokine, IL-10. Units: pg/mL, To evaluate the effect on clinical measures of neurological status: EDSS
Neurology